EPHB4 and neoplasm: The complementary results acquired with SPECT and NIRF in mice bearing the EphB4-positive PC-3 tumour revealed two times higher uptake by the tumour tissue and tumour-to-blood ratio for the NP-based conjugate 111In-TNYL-RAW-CCPM than for the NP-free 111In-TNYL-RAW conjugate.